FINNISH IMMUNOTECHNOLOGY LTD has a total of 15 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are OREGON HEALTH & SCIENCES UNIVE, ANDA BIOLOG SA and VITRUVIAN BIOMEDICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Finland | 2 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Krohn Kai | 11 |
#2 | Shimizu Nobuyoshi | 8 |
#3 | Kudoh Jun | 8 |
#4 | Antonarakis Stylianos | 7 |
#5 | Scott Hamish | 7 |
#6 | Peterson Paert | 6 |
#7 | Heino Maarit | 5 |
#8 | Lalioti Maria | 4 |
#9 | Palosuo Timo | 4 |
#10 | Turjanmaa Kristiina | 4 |
Publication | Filing date | Title |
---|---|---|
WO0161305A2 | Immunoassays detecting or making use of at least two rubber latexallergens | |
EP1220895A1 | Novel gene encoding a dna methyltransferase, dnmt3l | |
FI20002225A0 | Diagnostic method | |
FI982722A0 | Diagnostic method | |
AU9350298A | Novel gene defective in apeced and its use |